Prize Development Sponsors

XPRIZE would like to thank the following Prize Development Sponsors for their support:

ANA is Japan’s five-star international airline with 83 international routes and 116 domestic routes. Founded in 1952, ANA bridges the divide between places, people and their cultures. The airline prides itself on providing passengers with a unique and flawless journey through the airline’s relentless drive towards excellence, innovation and creativity. To learn more, click here.

Anytime Fitness is ranked #1 on Entrepreneur magazine’s prestigious Top Global Franchise list, Anytime Fitness is the fastest-growing fitness club franchise in the world, with more than 3,000 gyms and nearly 3,000,000 members worldwide. Open 24 hours a day, 365 days a year, Anytime Fitness prides itself on helping its members “Get to a Healthier Place” by providing them with surprisingly personable service in convenient and well-maintained facilities which feature top-quality exercise equipment. Clubs are now open in all 50 states, Canada, Mexico, Australia, New Zealand, England, Scotland, Ireland, Spain, Grand Cayman, Poland, Belgium, the Netherlands, Qatar, Chile, India, Singapore, Malaysia, Hong Kong, China, the Philippines, Taiwan and Japan. Join one club and use them all. Franchised clubs are individually owned and operated. For more information, visit www.anytimefitness.com

More than 20 million Americans have kidney diseases, which are a leading cause of death worldwide.  Representing nearly 16,000 kidney professionals in 114 countries, the American Society of Nephrology (ASN) leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. For more information, click here.

The Corporate and Investment Banking division of Barclays Africa is one of the few investment banks in the country able to leverage an extensive global network to provide a full suite of financing, investment and advisory solutions. Our approach is supported by products and services, access to world-class technology and product expertise as well as a strong balance sheet through Barclays Africa and Barclays PLC. Our intimate knowledge of local market dynamics ensures that our solutions are appropriate and competitive within sub-Saharan Africa. For more information, click here.

Corigin is a private holding company specializing in real estate and venture capital.  Corigin’s Real Estate Group is a preeminent developer, owner and operator of New York City and Miami real estate. The Group’s platforms span development, multi-family rental apartments, student housing, property management and lending.  Corigin Ventures is an early-stage investor of capital and support to tech-enabled startups in high-growth markets led by inspirational teams.  Free of limited partners or sector constraints, Corigin Ventures focuses on Seed and Series A investments. For more information, click here.

Established in 2008, the IDP Foundation, Inc. is dedicated to encouraging and supporting the development of innovative and sustainable solutions to complex global issues. We view our philanthropic dollars as patient, catalytic capital, allowing us the flexibility to support both local and international programs in a variety of ways.

Exemplifying this philanthropic approach is IDP Foundation’s keystone initiative, the IDP Rising Schools Program, which was developed in Ghana as a model for improving educational infrastructure in existing low-fee private schools that serve the poor. The IDP Rising Schools Program has demonstrated that with adequate training, low-fee private schools can improve their management and efficiently use their access to capital to sustain their schools. This multi-faceted program is rapidly scaling and is proving to be a viable, sustainable model that can be replicated around the world. For more information, click here.

New Profit is a national nonprofit venture philanthropy fund. The organization’s mission is to break down the barriers standing between people and opportunity in America. To do so, New Profit is working to transform the way America educates its children, propels people towards social and financial stability, and creates healthy communities. Since being founded in 1998, New Profit has collaborated with philanthropists, social entrepreneurs, foundations, businesses, policy advocates and other entities to help drive more than $1 billion towards innovative, disruptive approaches to social problem solving. New Profit’s unique, integrated approach brings together the following activities: investing through the New Profit Innovation Fund and Focus Funds; changing public policy through America Forward; and building communities of learning and action around innovative new approaches to change through the Gathering of Leaders and other activities. For more information, visit www.newprofit.org/

The Roddenberry Foundation supports and inspires efforts that create and expand new frontiers for the benefit of humanity. It funds innovative solutions to critical global issues in the areas of science and technology, the environment, education and humanitarian advances. For more information, click here.

The Steven & Alexandra Cohen Foundation is committed to inspiring philanthropy and community service – with special interest in children's health, education, veterans, and the arts – by creating awareness, offering guidance, and leading by example to show the world what giving can do. The Cohen Foundation's Lyme Initiative is investing to cure Lyme, which infects over 300,000 Americans each year and leaves 10-20% with persistent, life-altering symptoms.  Through funding leading researchers and innovators, the Foundation will improve our ability to prevent, diagnose, and treat all stages of Lyme disease. For more information, click here.

As one of the world's top research universities, UCLA addresses a range of society's most challenging problems, including the need for healthy organ transplantation. UCLA supports nationally and internationally recognized research programs in clinical transplantation and immunology, as well as in many related medical and surgical disciplines. This active research environment has led to the development of new and effective surgical techniques, immunosuppressive regimens, and protocols for the treatment of rejection and other critical medical complications of transplantation. UCLA constantly strives to look for new and innovative research and development in this area to ultimately create better and longer lives for transplant patients. For more information, click here.

Become a Part of the Future! Sign Up for Our Newsletter: